(Q37282166)

19 August 2017

1 reference

title

Special issues in the diagnosis and treatment of ADHD in adolescents (English)

1 reference

attention deficit hyperactivity disorder

19 August 2017

0 references

1 reference

0 references

author name string

Kenneth W Steinhoff

series ordinal

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

19 August 2017

published in

Postgraduate Medicine

1 reference

19 August 2017

volume

120

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

60-68

1 reference

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Studies on the hyperactive child. 8. Five-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Hyperactive boys almost grown up. I. Psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Clinical practice. Attention deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Attention-deficit/hyperactivity disorder and early-onset substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Correlates of comorbid psychopathology in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Childhood and adolescent depression: a review of the past 10 years. Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Puberty and depression: the roles of age, pubertal status and pubertal timing

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Defining clinical phenotypes of juvenile mania

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Aspects of social and emotional competence in adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Quality of life of adolescent males with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Do stimulants improve self-esteem in children with ADHD and peer problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

21 January 2018

Stimulant medications

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

Attention Deficit Hyperactivity Disorder (ADHD) is Associated with Early Onset Substance Use Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1908

21 January 2018

Identifiers

DOI

10.3810/PGM.2008.09.1908

1 reference

19 August 2017

1 reference